INVESTIGADORES
VIALE Diego Luis
congresos y reuniones científicas
BASTON, JI; VIALE, D. L.; OLGUIN, M; WEIDENMANN, E; ARNOLD, V; SUVA, M; LUZZANI, C; MIRIUKA, S; MORO, LN; VICHERA, G
Myostatin gene editing by CRISPR/Cas9 technology of Brangus fetal fibroblasts to produce edited embryos by cloning
47th Annual Conference of the International Embryo Technology Society
Lugar: Lima; Año: 2021;
KURTZ, M; LEZON, C; DELFOSSE, VC; VIALE, DL; BOYER, P; TASAT, D
Cumulative Risk Factors in the Urban Environment: Interaction Between Air Pollution and Malnutrition on the Immune Response of Alveolar Macrophages
SETAC Latin America 14th Biennial Meeting
Lugar: Virtual; Año: 2021;
VERONICA DELFOSSE; DIEGO VIALE; ANDREA GIOFFRE; LINA PAOLA D'ATRI; MELISA KURTZ; DEBORAH TASAT
Biología II: convirtiendo los desafíos de la virtualidad en nuevas potencialidades.
EXPERIENCIAS DE ENSEÑANZA EN PANDEMIA: DOCENTES Y VIRTUALIDAD
Lugar: San Martín, Buenos Aires - Argentina; Año: 2021;
VICHERA, G; VIALE, DL; OLIVERA, R; ARNOLD, V; GRUNDNIG, A; BASTON, J; MIRIUKA, S; MORO, L
Generation of myostatin knockout horse embryos using clustered regularly interspaced short palindromic repeats/CRISPR-associated gene 9 and somatic cell nuclear transfer
45th IETS Annual Conference of Sociedad International Embryo Tecnology Society (IETS)
Lugar: New Orleans, Lousiana; Año: 2019;
BASTÓN, JI; FANTI, T; MORO, LN; ARNOLD, V; SUVÁ, M; LUZZANI, C; OLGUÍN, M; MIRIUKA, S; VIALE, D; VICHERA, G
Generation of Myostatin Knock-out Cow Embryos Using CRISPR/CAS9-assisted Gene Editing and Somatic Cell Nuclear Transfer
XXXIII Annual Meeting of Sociedade Brasileira de Tecnologia de Embriões (SBTE)
Lugar: Ilha da Comandatuba, Bahia; Año: 2019;
CALVO, DS; PERANDONES, C; RAINA, GB; GIUGNI, JC; PELLENE, LA; MAIOLA, R; CUEVAS, SM; ROMANO, EA; CAPUTO, M; CORACH, D; VIALE, DL; MATA, IF; ZABETIAN, CP; MICHELI, FE; RADRIZZANI, M
Mosaicism of alpha-synuclein (SNCA) gene rearrangements in 2 unrelated cases of multiple system atrophy with predominant Parkinsonism (MSA-P): A link between Parkinson's disease (PD) and multiple system atrophy?
The International Parkinson and Movement Disorder Society?s 18th International Congress of Parkinson's Disease and Movement Disorders
Lugar: Estocolmo; Año: 2014;
LOPEZ, MV; CUNEO, N; VIALE, DL; BRAVO, AI; CURIEL, DT; PODHAJCER, OL
Uso de un Adenovirus Replicativo en un Modelo Preclinico de Adenocarcinoma de Ovario
LVII Reunión Anual de la Sociedad Argentina de Investigación Clínica
Lugar: Mar del Plata; Año: 2012;
VIALE, DL; LOPEZ, MV; CAFFERATA, EG; GOULD, D; CHERNAJOVSKY, Y; CURIEL, DT; PODHAJCER, OL
Therapeutic Efficacy and Safety Studies of a Novel Oncolytic Adenovirus Active in Tumor-Associated Stromal Cells and Tumor Microenvironment
14th Annual Meeting of the American Society of Gene and Cell Therapy
Lugar: Seattle, Washington; Año: 2011;
VIALE, DL; LOPEZ, MV; CAFFERATA, EG; GOULD, D; CHERNAJOVSKY, Y; PODHAJCER, OL
Improving the Lytic Capacity of a Conditionally Replicative Adenoviruses by Incorporating Promoter Elements Responsive to Tumor Environmental Conditons
13th Annual Meeting of American Society of Gene and Cell Therapy
Lugar: Marriott Wardman Park Hotel, Washington, DC, USA; Año: 2010;
LOPEZ, MV; RIVERA, AA; BENEDETTI, L; VIALE, DL; KIMBALL, KJ; WANG, M; BRAVO, AI; DORVAULT, C; DOUGLAS, J; ZHU, ZB; ALVAREZ, RD; CURIEL, DT; PODHAJCER, OL
Incorporation of a Mutated E1A and a Chimeric 5/3 Fiber Improved the Therapeutic Ef cacy of a Novel CRAd (Ad-F512) on Disseminated Ovarian Cancer
13th Annual Meeting of The American Society of Gene and Cell Therapy
Lugar: Marriott Wardman Park Hotel, Washington, DC, USA; Año: 2010;
LOPEZ, MV; VIALE, DL; CAFFERATA, EGA; PODHAJCER, OL
Soluble Factors Produced by Stromal Cells Greatly Influence Adenoviral Oncolytic Efficacy
12th Annual Meeting of the American Society of Gene Therapy
Lugar: San Diego, California, USA; Año: 2009;
LOPEZ, MV; VIALE, DL; CAFFERATA EG; WU, H; RIVERA, AA; GOULD, D; CHERNAJOVSKY, Y; CURIEL, DT; PODHAJCER, OL
Targeting malingnant and tumor associated-stromal cells as a novel strategy for cancer gene therapy
In vivo barriers to gene delivery
Lugar: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; Año: 2009;
LOPEZ, MV; VIALE, DL; CAFFERATA, EA; GOULD, D; CHERNAJOVSKY, Y; PODHAJCER, OL
Adenoviral Oncolytic Capacity Is Defined by Tumor Cell-Stroma Interaction
11th Annual Meeting of the American Society of Gene Therapy
Lugar: Boston, Massachusetts, USA; Año: 2008;
LOPEZ, MV; VIALE, DL; CAFFERATA, EG; PODHAJCER, OL
Stromal Cells Play a Critical Role in the Outcome of the Oncolytic Efficacy of Conditional Replicative Adenoviruses
AACR Centennial Conference - Translationa Cancer Medicine 2008
Lugar: IIC Jerusalem International Convention Center, Jerusalem, Israel; Año: 2008;
LOPEZ, MV; VIALE, DL; CAFFERATA EG; WU, H; RIVERA, AA; GOULD, D; CHERNAJOVSKY, Y; CURIEL, DT; PODHAJCER, OL
Targeting malingnant and tumor associated-stromal cells as a novel strategy for cancer gene therapy
In vivo barriers to gene delivery
Lugar: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; Año: 2007;
LOPEZ, MV; VIALE, DL; CAFFERATA, EG; PODHAJCER, OL
A novel SPARC-driven oncolytic adenovirus therapeutically effective in both cancer and tumor-associated stromal cells
James S. McDonnell Foundation Workshop Tango Lessons for Brain Cancer Research: Understanding Cellular Intricacy, Improvising New Therapies
Lugar: Hotel El Castillo, Cordoba, Argentina; Año: 2007;
CAFFERATA, EG; MACCIO, DR; LOPEZ, MV; VIALE, DL; PODHAJCER, OL
Specific Oncolytic Adenovirus Driven by Human A33 Promoter Region for Colorectal Cancer Therapy
9th Annual Meeting of the American Society of Gene Therapy
Lugar: Baltimore, MD, USA; Año: 2006;
LOPEZ, MV; VIALE, D; CAFFERATA, EG; MACCIO, DR; GOULD, D; CHERNAJOVSKY, Y; PODHAJCER, OL
A Novel Pan-Oncolytic Adenovirus Therapeutically Effective in Different Cancer Cell Types
9th Annual Meeting of the American Society of Gene Therapy
Lugar: Baltimore, MD, USA; Año: 2006;
VIALE, DL; LOPEZ, MV; CAFFERATA, EG; GOULD, D; CHERNAJOVSKY, Y; PODHAJCER, OL
Characterization of a SPARC promoter suitable for cancer gene therapy
XLII Reunión Anual de la Sociedad Argentina de Investigación en Bioquímica y Biología Molecular
Lugar: Rosario, Santa Fé, Argentina; Año: 2006;
CAFFERATA, EGA; MACCIO, DR; LOPEZ, MV; VIALE, DL; CARBONE, C; PODHAJCER, OL
A novel specific oncolytic adenovirus driven by human A33 promoter for Colorectal Cancer therapy.
XLII Reunión Anual de la Sociedad Argentina de Investigación en Bioquímica y Biología Molecular
Lugar: Centro Cultural Parque de España, Rosario, Santa Fé, Argentina; Año: 2006;
LOPEZ, MV; VIALE, DL; CAFFERATA, EG; MACCIO, DR; CARBONE, C; GOULD, D; CHERNAJOVSKY, Y; PODHAJCER, OL
A novel oncolytic adenovirus therapeutically effective in melanoma tumor.
XLII Reunión Anual de la Sociedad Argentina de Investigación en Bioquímica y Biología Molecular
Lugar: Rosario, Santa Fé, Argentina; Año: 2006;
LOPEZ, MV; BLANCO, P; VIALE, DL; CAFFERATA, EG; GOULD D; CHERNAJOVSKY Y; PODHAJCER, OL
Expression of the Herpes Simplex Virus Thymidine Kinase Gene by a Promoter Region of the Human SPARC Gene Inhibits Human Melanoma Cell Growth In Vitro and In Vivo
Eighth Annual Meeting of the American Society of Gene Therapy
Lugar: America's Center, St. Louis, MO, USA; Año: 2005;